Clinical Trials Browser

Withdrawn × Cholangiocarcinoma × Gemcitabine × Clear all

NCT05514912 2023-12-26

Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma

NCT04546828 2022-06-15

A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma

NCT04480190 2022-04-20

Neoadjuvant Therapy in Biliary Adenocarcinoma

Phase 1 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT00713687 2012-08-10

GemOx-PDT

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma